Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Chemomab Therapeutics to Participate in Upcoming Investor Conferences | ||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 05 Feb 2024 | Back to overview list |
|||||||||||||||||||||||||||
TEL AVIV, Israel, Feb. 5, 2024 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that CEO Dr. Adi Mor and other members of its senior management team will participate in two upcoming investor conferences. Dr. Mor will deliver a corporate presentation and participate in one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference, February 13-14, 2024 (virtual), and the Leerink Partners Global Biopharma Conference, March 11-13, 2024 in Miami, Florida. The Oppenheimer Conference presentation will be webcast live and will be available on the investor relations section of the Chemomab website for 90 days.
About Chemomab Therapeutics Ltd. Contacts: Media and Investors: View original content to download multimedia:https://www.prnewswire.com/news-releases/chemomab-therapeutics-to-participate-in-upcoming-investor-conferences-302052924.html SOURCE Chemomab Therapeutics, Ltd. |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |